
Health Canada Approves Relora Stress-Relief Supplement
Relora’s developer, Next Pharmaceuticals (Salinas, CA), says Relora works by “quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness.”
Health Canada has issued
Relora’s developer, Next Pharmaceuticals (Salinas, CA), says Relora works by “quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness.” It is a blend of Magnolia officinalis and Phellodendron amurense bark extracts.
Relora has been sold in the United States since 2000 under patent (#6,582,735).
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





